| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.45▲ | 1.45▲ | 1.44▲ | 1.46▼ | 1.60▼ |
| MA10 | 1.45▲ | 1.43▲ | 1.44▲ | 1.45▼ | 1.84▼ |
| MA20 | 1.44▲ | 1.44▲ | 1.46▼ | 1.61▼ | 1.88▼ |
| MA50 | 1.42▲ | 1.46▼ | 1.44▲ | 1.88▼ | 1.90▼ |
| MA100 | 1.44▲ | 1.44▲ | 1.50▼ | 1.90▼ | 1.51▼ |
| MA200 | 1.47▼ | 1.51▼ | 1.74▼ | 1.91▼ | 8.22▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.005▲ | -0.002▼ | 0.002▲ | -0.079▼ |
| RSI | 66.003▲ | 53.746▲ | 50.395▲ | 36.084▼ | 38.630▼ |
| STOCH | 66.667 | 84.190▲ | 47.667 | 45.385 | 24.930 |
| WILL %R | -14.286▲ | -22.222▲ | -26.316 | -66.667 | -85.792▼ |
| CCI | 77.778 | 82.051 | 19.188 | -64.794 | -146.458▼ |
| ▲ MACD | $PALI MACD(12,26,9) Crossed Above Signal Line | Set Alert |
|
Monday, September 28, 2026 01:50 AM
Oral presentation to highlight early endoscopic improvement and evidence of PDE4 target engagement in fibrostenotic Crohn’s diseaseThree ...
|
|
Tuesday, September 22, 2026 01:35 AM
ASCENTRA-CD expected to enroll approximately 60 patients with moderate to severe Crohn’s diseaseFirst patient dosing targeted for Q1 2027; ...
|
|
Thursday, June 11, 2026 05:45 AM
Company continues to build on PALI-2108 clinical progress as it advances toward Phase 2 development and additional key milestones Denver, CO, June 11, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/10/26 | 1.47 | 1.48 | 1.38 | 1.45 | 1,984,403 |
| 07/10/26 | 1.46 | 1.48 | 1.44 | 1.48 | 825,232 |
| 06/10/26 | 1.51 | 1.55 | 1.47 | 1.49 | 1,972,700 |
| 05/10/26 | 1.44 | 1.48 | 1.41 | 1.46 | 1,590,487 |
| 02/10/26 | 1.46 | 1.48 | 1.425 | 1.44 | 1,991,484 |
| 01/10/26 | 1.39 | 1.46 | 1.37 | 1.43 | 2,645,190 |
| 30/09/26 | 1.44 | 1.46 | 1.32 | 1.35 | 4,750,862 |
| 29/09/26 | 1.54 | 1.5494 | 1.42 | 1.45 | 2,160,710 |
| 28/09/26 | 1.45 | 1.53 | 1.43 | 1.50 | 8,681,927 |
| 25/09/26 | 1.57 | 1.59 | 1.45 | 1.45 | 5,719,813 |
|
|
||||
|
|
||||
|
|